Urinary 6β-hydroxycortisol excretion in Hong Kong Chinese patients with hepatocellular carcinoma and other chronic liver diseases

Cancer

Volumn 77, Issue 8, 1996, Pages 1427-1433

  Ng, Maggie C Y ^a   Young, Robert P ^a   Critchley, Julian A J H ^a   Leung, Nancy W Y ^a   Lau, Joseph W Y ^a   Li, Arthur K C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

6 hydroxycortisol; carcinogenesis; cytochrome P 450; hepatocellular carcinoma

Indexed keywords

6BETA HYDROXYHYDROCORTISONE; AFLATOXIN B1; CYTOCHROME P450;

ADULT; ARTICLE; BIOTRANSFORMATION; CARCINOGENESIS; CHRONIC LIVER DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HYDROCORTISONE URINE LEVEL; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHINA; CHRONIC DISEASE; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HONG KONG; HUMANS; HYDROCORTISONE; ISOENZYMES; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; MIXED FUNCTION OXYGENASES;

EID: 0029912350     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960415)77:8<1427::AID-CNCR2>3.0.CO;2-9     Document Type: Article

References (24)

1. Leung NWY, Critchley JAJH. Increased oxidative metabolism of paracetamol in patients with hepatocellular carcinoma. Cancer Lett 1991;57:45-8.
2. Murray GI, Barnes TS, Sewell HF. The immunocytochemical localization and distribution of cytochrome P450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P450. Br J Clin Pharmacol 1988;25:465-75.
3. Kolars J, Schmiedelin-Ren P, Dobbins W, Merion R, Wrighton S, Watkins P. Heterogeneity of P-450 IIIA expression in human gut epithelia. FASEB J 1990;4:A2242.
4. Burstein S, Kimball HL, Klaiber EL, Gut M. Metabolism of 2α- and 6β-hydroxycortisol in man: determination of production rate of 6β-hydroxycortisol with and without phenobarbital administration. J Clin Endocrinol 1967;27:491-9.
5. Price DE, Mehta A, Park BK, Hay A, Feely MP. The effect of low-dose phenobarbitone on three indices of hepatic microsomal enzyme induction. Br J Clin Pharmacol 1986;22:744-7.
6. Desager JP, Dumont E, Harvengt C. The urinary 6β-hydroxycortisol excretion in man on inducers and inhibitors of the hepatic mixed function oxidase. Pharmacol Ther 1987;33: 197-9.
7. Ohnhaus EE, Breckenridge AM, Park BK. Urinary excretion of 6β-hydroxycortisol and the time course measurement of enzyme induction in man. Eur J Clin Pharmacol 1989;36:39-46.
8. Park BK, Breckenridge AM. Clinical implication of enzyme induction and enzyme inhibition. Clin Pharmacokinet 1981;6:1-24.
9. Ged C, Rouillon JM, Pichard L, Combalbert J, Bressot N, Bories P, et al. The increase in urinary excretion of 6β-hydroxycortisol as a marker of human hepatic cytochrome P450I-IIA induction. Br J Clin Pharmacol 1989;28:373-87.
10. Zhiri A, Mayer HA, Michaux V, Bednawska MW, Siest G. 6β-hydroxycortisol in serum and urine as determined by enzyme immunoassay on microtitre plates. Clin Chem 1986;32:2094-7.
11. Saenger P. 6β-hydroxycortisol in random urine samples as an indicator of enzyme induction. Clin Pharmacol Ther 1983;34:818-21.
12. Zhiri A, Wellman-Bednamska M, Siest G. ELISA of 6-beta-hydrocortisol in human urine: diurnal variation and effects of antiepileptic therapy. Clin Chim Acta 1986;157:267-76.
13. Saenger P, Forster E, Kream J. 6β-hydroxycortisol: a noninvasive indicator of enzyme induction. J Clin Endocrinol Metab 1981;52:381-4.
14. Park BK. A direct radioimmunoassay for 6β-hydroxycortisol in human urine. J Steroid Biochem 1977;9:963-6.
15. Nakamura J, Yakata M. Determination of urinary cortisol and 6β-hydroxycortisol by high performance liquid chromatography. Clin Chim Acta 1985;149:215-24.
16. Bienvenu T, Rey E, Pons G, Athis PD, Olive G. A simple noninvasive procedure for the investigation of cytochrome P-450 IIIA dependent enzymes in humans. Int J Clin Pharmacol Ther Toxicol 1991;29:441-5.
17. Canalis E, Reardon GE, Caldarella AM. A more specific, liquid-chromatographic method for free cortisol in urine. Clin Chem 1982;28:2418-20.
18. Joellenbeck L, Qian Z, Zarba A, Groopman JD. Urinary 6β-hydroxycortisol/cortisol ratios measured by high-performance liquid chromatography for use as a biomarker for the human cytochrome P450 3A4. Cancer Epidemiol Biomarkers Prey 1992;1:567-72.
19. Philip PA, Kaklamanis L, Ryley N, Stratford I, Wolf R, Harris A, et al. Expression of xenobiotic-metabolizing enzymes by primary and secondary hepatic tumors in man. Int J Radiat Oncol Biol Phys 1994;29:277-83.
20. Kovalszky I, Schaff Z, Jeney A. Potential markers (enzymes, proteoglycans) for human liver tumors. Acta Biomed Ateneo Parmense 1993;64:157-63.
21. Ayesh R, Idle JR, Ritchie JC, Crothers MJ, Hetzel MR. Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Nature 1984;312:169-70.
22. Idle JR, Mahgoub A, Sloan TP, Smith RL, Mbanefo CO, Bababunmi EA. Some observations on the oxidative phenotype status of Nigerian patients presenting with cancer. Cancer Lett 1981;11:331-8.
23. Guengerich FP. Oxidation of toxic and carcinogenic chemicals by human cytochrome P450 enzymes. Chem Res Toxicol 1991;4:391-407.
24. Lau GSN. Metabolic activation of drugs and other xenobiotics in hepatocellular carcinoma [Ph.D. thesis]. Shatin (Hong Kong): The Chinese University of Hong Kong; 1993, 420 pp.